BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12707289)

  • 1. Reduced growth factor responses in vascular smooth muscle cells derived from 12/15-lipoxygenase-deficient mice.
    Reddy MA; Kim YS; Lanting L; Natarajan R
    Hypertension; 2003 Jun; 41(6):1294-300. PubMed ID: 12707289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential behavior of mesangial cells derived from 12/15-lipoxygenase knockout mice relative to control mice.
    Kim YS; Reddy MA; Lanting L; Adler SG; Natarajan R
    Kidney Int; 2003 Nov; 64(5):1702-14. PubMed ID: 14531803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of MAPK and 12-lipoxygenase pathways in growth and matrix protein expression in mesangial cells.
    Reddy MA; Adler SG; Kim YS; Lanting L; Rossi J; Kang SW; Nadler JL; Shahed A; Natarajan R
    Am J Physiol Renal Physiol; 2002 Nov; 283(5):F985-94. PubMed ID: 12372774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The oxidized lipid and lipoxygenase product 12(S)-hydroxyeicosatetraenoic acid induces hypertrophy and fibronectin transcription in vascular smooth muscle cells via p38 MAPK and cAMP response element-binding protein activation. Mediation of angiotensin II effects.
    Reddy MA; Thimmalapura PR; Lanting L; Nadler JL; Fatima S; Natarajan R
    J Biol Chem; 2002 Mar; 277(12):9920-8. PubMed ID: 11786549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Src tyrosine kinase in the atherogenic effects of the 12/15-lipoxygenase pathway in vascular smooth muscle cells.
    Reddy MA; Sahar S; Villeneuve LM; Lanting L; Natarajan R
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):387-93. PubMed ID: 19095999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TLR 2 induces vascular smooth muscle cell migration through cAMP response element-binding protein-mediated interleukin-6 production.
    Lee GL; Chang YW; Wu JY; Wu ML; Wu KK; Yet SF; Kuo CC
    Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2751-60. PubMed ID: 22995520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CREB-mediated IL-6 expression is required for 15(S)-hydroxyeicosatetraenoic acid-induced vascular smooth muscle cell migration.
    Chava KR; Karpurapu M; Wang D; Bhanoori M; Kundumani-Sridharan V; Zhang Q; Ichiki T; Glasgow WC; Rao GN
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):809-15. PubMed ID: 19342597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of 12/15-lipoxygenase in the expression of interleukin-6 and tumor necrosis factor-alpha in macrophages.
    Wen Y; Gu J; Chakrabarti SK; Aylor K; Marshall J; Takahashi Y; Yoshimoto T; Nadler JL
    Endocrinology; 2007 Mar; 148(3):1313-22. PubMed ID: 17170102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral vector-mediated 12/15-lipoxygenase overexpression in vascular smooth muscle cells enhances inflammatory gene expression and migration.
    Dwarakanath RS; Sahar S; Lanting L; Wang N; Stemerman MB; Natarajan R; Reddy MA
    J Vasc Res; 2008; 45(2):132-42. PubMed ID: 17943024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 12-lipoxygenase pathway increases aldosterone production, 3',5'-cyclic adenosine monophosphate response element-binding protein phosphorylation, and p38 mitogen-activated protein kinase activation in H295R human adrenocortical cells.
    Gu J; Wen Y; Mison A; Nadler JL
    Endocrinology; 2003 Feb; 144(2):534-43. PubMed ID: 12538614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of leukocyte-type 12/15-lipoxygenase on Id3-mediated vascular smooth muscle cell growth.
    Taylor AM; Hanchett R; Natarajan R; Hedrick CC; Forrest S; Nadler JL; McNamara CA
    Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2069-74. PubMed ID: 16037566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased 12/15-lipoxygenase enhances cell growth, fibronectin deposition, and neointimal formation in response to carotid injury.
    Deliri H; Meller N; Kadakkal A; Malhotra R; Brewster J; Doran AC; Pei H; Oldham SN; Skaflen MD; Garmey JC; McNamara CA
    Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):110-6. PubMed ID: 20947825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aldosterone up-regulates 12- and 15-lipoxygenase expression and LDL oxidation in human vascular smooth muscle cells.
    Limor R; Kaplan M; Sharon O; Knoll E; Naidich M; Weisinger G; Keidar S; Stern N
    J Cell Biochem; 2009 Dec; 108(5):1203-10. PubMed ID: 19795383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered GLUT4 translocation in skeletal muscle of 12/15-lipoxygenase knockout mice.
    Vahsen S; Rakowski K; Ledwig D; Dietze-Schroeder D; Swifka J; Sasson S; Eckel J
    Horm Metab Res; 2006 Jun; 38(6):391-6. PubMed ID: 16823721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoxygenase-derived metabolites are regulators of peroxisome proliferator-activated receptor gamma-2 expression in human vascular smooth muscle cells.
    Limor R; Sharon O; Knoll E; Many A; Weisinger G; Stern N
    Am J Hypertens; 2008 Feb; 21(2):219-23. PubMed ID: 18202670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular smooth muscle cell proliferation requires both p38 and BMK1 MAP kinases.
    Zhao M; Liu Y; Bao M; Kato Y; Han J; Eaton JW
    Arch Biochem Biophys; 2002 Apr; 400(2):199-207. PubMed ID: 12054430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the lipoxygenase pathway in angiotensin II-induced vascular smooth muscle cell hypertrophy.
    Natarajan R; Gonzales N; Lanting L; Nadler J
    Hypertension; 1994 Jan; 23(1 Suppl):I142-7. PubMed ID: 8282345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical role of macrophage 12/15-lipoxygenase for atherosclerosis in apolipoprotein E-deficient mice.
    Huo Y; Zhao L; Hyman MC; Shashkin P; Harry BL; Burcin T; Forlow SB; Stark MA; Smith DF; Clarke S; Srinivasan S; Hedrick CC; Praticò D; Witztum JL; Nadler JL; Funk CD; Ley K
    Circulation; 2004 Oct; 110(14):2024-31. PubMed ID: 15451785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. cAMP response element-binding protein mediates thrombin-induced proliferation of vascular smooth muscle cells.
    Tokunou T; Ichiki T; Takeda K; Funakoshi Y; Iino N; Takeshita A
    Arterioscler Thromb Vasc Biol; 2001 Nov; 21(11):1764-9. PubMed ID: 11701463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quercetin glucuronide prevents VSMC hypertrophy by angiotensin II via the inhibition of JNK and AP-1 signaling pathway.
    Yoshizumi M; Tsuchiya K; Suzaki Y; Kirima K; Kyaw M; Moon JH; Terao J; Tamaki T
    Biochem Biophys Res Commun; 2002 May; 293(5):1458-65. PubMed ID: 12054679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.